Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 4 3Phase 3 2Phase 2 2Phase NA 1

Status

Completed 9Terminated 2Withdrawn 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Cholangiocarcinoma 2Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Photochemotherapy × Clear all
NCT00907413 2015-06-03

PDT

Weill Medical College of Cornell University

Phase 3 Terminated
50 enrolled
Gastrointestinal

Neoplasms, Cholangiocarcinoma

NCT00540735 2010-02-04

CK/PDT

University Hospital, Angers

Phase 3 Terminated
80 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡